A non-interventional, post authorization safety study to evaluate the safety of Kineret in
the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with
regard to serious infections, malignancies, injection site reactions, allergic reactions and
medication errors, including re-use of syringe.
Details
Lead Sponsor:
Swedish Orphan Biovitrum
Collaborator:
Pediatric Rheumatology International Trials Organization